Replies to post #243410 on Biotech Values

[DewDiligence]

KRTX sells 4.01M* shares @$215.00—a 7% discount to yesterday’s close:

https://www.businesswire.com/news/home/20220809006121/en

Wow. The net proceeds after underwriting fees will be more than $800M.*

*Assuming exercise of underwriter’s option.

[DewDiligence]

BMY acquires KRTX for $330/sh cash—a 53% premium to Thursday’s close:

https://finance.yahoo.com/news/bristol-myers-squibb-strengthens-neuroscience-120500513.html

The nominal deal value is $14B; after deducting KRTX’s $1.3B of net cash, the equity value is $12.7B.